The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Ingram Elizabeth Garrett since 2019.
The trader's CIK number is 1743688.
At the time of the last reporting, Ingram Elizabeth Garrett was the Chief Marketing Officer of Avenue Therapeutics, Inc.. (stock ticker symbol ATXI).
Also see all insider trading activities at Avenue Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | MNKD | 5,000 | $5,350 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | ATXI | 16,000 | $100,320 | 0 | $0 | 0 | $0 |
2. Avenue Therapeutics, Inc. (ATXI)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-01-31 | MNKD | Buy | 5,000 | 1.07 | 5,350 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-09-12 | ATXI | Buy | 16,000 | 6.27 | 100,320 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ingram Elizabeth Garrett (Chief Marketing Officer of Avenue Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.